115 related articles for article (PubMed ID: 28638887)
1. A MOUSE MODEL OF MAMMARY HYPERPLASIA INDUCED BY ORAL HORMONE ADMINISTRATION.
Sun L; Guo DH; Liu F; Liu Q; Jiang N; Sun YF; Cai LP; Zheng HX
Afr J Tradit Complement Altern Med; 2017; 14(4):247-252. PubMed ID: 28638887
[TBL] [Abstract][Full Text] [Related]
2. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.
Montero Girard G; Vanzulli SI; Cerliani JP; Bottino MC; Bolado J; Vela J; Becu-Villalobos D; Benavides F; Gutkind S; Patel V; Molinolo A; Lanari C
Breast Cancer Res; 2007; 9(2):R22. PubMed ID: 17341305
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
4. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
5. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.
Harvell DM; Strecker TE; Tochacek M; Xie B; Pennington KL; McComb RD; Roy SK; Shull JD
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2779-84. PubMed ID: 10688907
[TBL] [Abstract][Full Text] [Related]
6. An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations.
Yang CH; Almomen A; Wee YS; Jarboe EA; Peterson CM; Janát-Amsbury MM
Cancer Med; 2015 Jul; 4(7):1039-50. PubMed ID: 25809780
[TBL] [Abstract][Full Text] [Related]
7. Prolactin mediation of estrogen-induced changes in mammary tissue estrogen and progesterone receptors.
Muldoon TG
Endocrinology; 1987 Jul; 121(1):141-9. PubMed ID: 3595517
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Lubeikangru formulation in mice with hyperplasia of the mammary glands induced by estrogen and progesterone.
Sun L; Guo D; Liu Q; Xue Y; Jiang N; Zheng H
J Tradit Chin Med; 2019 Apr; 39(2):174-180. PubMed ID: 32186039
[TBL] [Abstract][Full Text] [Related]
10. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
Sampayo R; Recouvreux S; Simian M
Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
[TBL] [Abstract][Full Text] [Related]
11. Induction of mammary gland development in estrogen receptor-alpha knockout mice.
Bocchinfuso WP; Lindzey JK; Hewitt SC; Clark JA; Myers PH; Cooper R; Korach KS
Endocrinology; 2000 Aug; 141(8):2982-94. PubMed ID: 10919287
[TBL] [Abstract][Full Text] [Related]
12. Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium.
Yap SP; Shen P; Li J; Lee LS; Yong EL
J Ethnopharmacol; 2007 Sep; 113(2):218-24. PubMed ID: 17628368
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
14. Modified Estrogen-Progesterone Induction Method of Mammary Gland Hyperplasia in Rats.
Semenov AL; Tyndyk ML; Von YD; Radetskaya EA; Kruglov AS; Dorofeeva AA; Mizgirev IV; Ermakova ED; Panchenko AV
Bull Exp Biol Med; 2023 May; 175(1):112-115. PubMed ID: 37336808
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J
J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557
[TBL] [Abstract][Full Text] [Related]
16. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
[TBL] [Abstract][Full Text] [Related]
17. [Effects of encircled needling plus electroacupuncture on hyperplastic mammary glands and serum sex hormones in the rat].
Yang JJ; Wang LN; Xiao HL; Zhang SC; She YF; Bian WJ; Guo S
Zhen Ci Yan Jiu; 2012 Jun; 37(3):173-8. PubMed ID: 22934385
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.
Tekmal RR; Liu YG; Nair HB; Jones J; Perla RP; Lubahn DB; Korach KS; Kirma N
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):9-15. PubMed ID: 15955696
[TBL] [Abstract][Full Text] [Related]
19. [Effects of kidney reinforcing and blood circulation activating Chinese medicine on morphological structure of mammary glands in models of mammary atrophy and hyperplasia in female rats].
Li PY; Ouyang HQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jun; 21(6):448-52. PubMed ID: 12577443
[TBL] [Abstract][Full Text] [Related]
20. Cervicovaginal and mammary gland abnormalities in BALB/cCrgl mice treated neonatally with progesterone and estrogen, alone or in combination.
Jones LA; Bern HA
Cancer Res; 1979 Jul; 39(7 Pt 1):2560-7. PubMed ID: 445458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
